Serum amyloid A and atherosclerosis

Current Opinion in Lipidology

Volumn 27, Issue 5, 2016, Pages 531-535

  Getz, Godfrey S ^a   Krishack, Paulette A ^a   Reardon, Catherine A ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Atherosclerosis; Hdl; Inflammation; Serum amyloid a

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; ISOPROTEIN; SERUM AMYLOID A;

ARTERY WALL; ATHEROGENESIS; ATHEROSCLEROSIS; CHOLESTEROL TRANSPORT; HUMAN; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; ARTERY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; ARTERIES; ATHEROSCLEROSIS; CHOLESTEROL; HUMANS; LIPOPROTEINS, HDL; SERUM AMYLOID A PROTEIN; SIGNAL TRANSDUCTION;

EID: 84987788963     PISSN: 09579672     EISSN: 14736535     Source Type: Journal    
DOI: 10.1097/MOL.0000000000000331     Document Type: Review

References (44)

1. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342:836-843.
2. Chait A, Han CY, Oram JF, Heinecke JW. Thematic review series: The immune system and atherogenesis. Lipoprotein-Associated inflammatory proteins: markers or mediators of cardiovascular disease? J Lipid Res 2005; 46:389-403.
3. Johnson BD, Kip KE, Marroquin OC, et al. Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: The National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation 2004; 109:726-732.
4. Deguchi H, Elias DJ, Navarro S, et al. Elevated serum amyloid A is associated with venous thromboembolism. Thromb Haemost 2013; 109:358-359.
5. Carty CL, Heagerty P, Heckbert SR, et al. Association of genetic variation in serum amyloid-A with cardiovascular disease and interactions with IL6, IL1RN, IL1b and TNF genes in the Cardiovascular Health Study. J Athero Thromb 2009; 16:419-430.
6. Meek RL, Urieli-Shoval S, Benditt EP. Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function. Proc Natl Acad Sci U S A 1994; 91:3186-3190.
7. Uhlar CM, Whitehead AS. Serum amyloid A, the major vertebrate acute-phase reactant. Eur J Biochem 1999; 265:501-523.
8. Chiba T, Han CY, Vaisar T, et al. Serum amyloid A3 does not contribute to circulating SAA levels. J Lipid Res 2009; 50:1353-1362.
9. Frame NM, Gursky O. Structure of serum amyloid A suggests a mechanism for selective lipoprotein binding and functions: SAA as a hub in macromolecular interaction networks. FEBS Lett 2016; 590:866-879.
10. Jahangiri A, Wilson PG, Hou T, et al. Serum amyloid A is found on ApoBcontaining lipoproteins in obese humans with diabetes. Obesity 2013; 21:993-996.
11. Eklund KK, Niemi K, Kovanen PT. Immune functions of serum amyloid A. Crit Rev Immunol 2012; 32:335-348.
12. Chen M, Zhou H, Cheng N, et al. Serum amyloid A1 isoforms display different efficacy at Toll-like receptor 2 and formyl peptide receptor 2. Immunobiology 2014; 219:916-923.
13. Song C, Hsu K, Yamen E, et al. Serum amyloid A induction of cytokines in monocytes/macrophages and lymphocytes. Atherosclerosis 2009; 207: 374-383.
14. Badolato R, Wang JM, Murphy WJ, et al. Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes. J Exp Med 1994; 180:203-209.
15. Su SB, Gong W, Gao JL, et al. A seven-Transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J Exp Med 1999; 189:395-402.
16. Ye RD, Sun L. Emerging functions of serum amyloid A in inflammation. J Leukoc Biol 2015; 98:923-929.
17. Lee HY, Kim SD, Shim JW, et al. Serum amyloid A induces CCL2 production via formyl peptide receptor-like 1-mediated signaling in human monocytes. J Immunol 2008; 181:4332-4339.
18. Duewell P, Kono H, Rayner KJ, et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 2010; 464:1357-1361.
19. Lewis KE, Kirk EA, McDonald TO, et al. Increase in serum amyloid a evoked by dietary cholesterol is associated with increased atherosclerosis in mice. Circulation 2004; 110:540-545.
20. Van Lenten BJ, Hama SY, de Beer FC, et al. Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J Clin Invest 1995; 96:2758-2767.
21. Han CY, Tang C, Guevara ME, et al. Serum amyloid A impairs the antiinflammatory properties of HDL. J Clin Invest 2016; 126:266-281.
22. Tam SP, Flexman A, Hulme J, Kisilevsky R. Promoting export of macrophage cholesterol: The physiological role of a major acute-phase protein, serum amyloid A 2.1. J Lipid Res 2002; 43:1410-1420.
23. Kisilevsky R, Tam SP. Macrophage cholesterol efflux and the active domains of serum amyloid A 2.1. J Lipid Res 2003; 44:2257-2269.
24. Stonik JA, Remaley AT, Demosky SJ, et al. Serum amyloid A promotes ABCA1-dependent and ABCA1-independent lipid efflux from cells. Biochem Biophys Res Commun 2004; 321:936-941.
25. van der Westhuyzen DR, Cai L, de Beer MC, de Beer FC. Serum amyloid A promotes cholesterol efflux mediated by scavenger receptor B-I. J Biol Chem 2005; 280:35890-35895.
26. Cai L, de Beer MC, de Beer FC, van der Westhuyzen DR. Serum amyloid A is a ligand for scavenger receptor class B type I and inhibits high density lipoprotein binding and selective lipid uptake. J Biol Chem 2005; 280:2954- 2961.
27. Kim MH, De Beer MC, Wroblewski JM, et al. Impact of individual acute phase serum amyloid A (SAA) isoforms on HDL metabolism in mice. J Lipid Res 2016. [Epub ahead of print].
28. de Beer MC, Webb NR, Whitaker NL, et al. SR-BI selective lipid uptake: subsequent metabolism of acute phase HDL. Arterioscler Thromb Vasc Biol 2009; 29:1298-1303.
29. McGillicuddy FC, de la Llera Moya M, Hinkle CC, et al. Inflammation impairs reverse cholesterol transport in vivo. Circulation 2009; 119:1135- 1145.
30. de Beer MC, Wroblewski JM, Noffsinger VP, et al. The impairment of macrophage-To-feces reverse cholesterol transport during inflammation does not depend on serum amyloid A. J Lipids 2013; 2013:283486.
31. Vaisar T, Tang C, Babenko I, et al. Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity. J Lipid Res 2015; 56:1519- 1530.
32. Pamir N, Hutchins P, Ronsein G, et al. Proteomic analysis of HDL from inbred mouse strains implicates APOE associated with HDL in reduced cholesterol efflux capacity via the ABCA1 pathway. J Lipid Res 2016; 57:246-257.
33. Banka CL, Yuan T, de Beer MC, et al. Serum amyloid A (SAA): influence on HDL-mediated cellular cholesterol efflux. J Lipid Res 1995; 36:1058-1065.
34. O'Brien KD, McDonald TO, Kunjathoor V, et al. Serum amyloid A and lipoprotein retention in murine models of atherosclerosis. Arterioscler Thromb Vasc Biol 2005; 25:785-790.
35. Chiba T, Chang MY, Wang S, et al. Serum amyloid A facilitates the binding of high-density lipoprotein from mice injected with lipopolysaccharide to vascular proteoglycans. Arterioscler Thromb Vasc Biol 2011; 31:1326- 1332.
36. Dong Z, Wu T, Qin W, et al. Serum amyloid A directly accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. Mol Med 2011; 17:1357-1364.
37. Thompson JC, Jayne C, Thompson J, et al. A brief elevation of serum amyloid A is sufficient to increase atherosclerosis. J Lipid Res 2015; 56:286-293.
38. Reardon CA, Blachowicz L, White T, et al. Effect of immune deficiency on lipoproteins and atherosclerosis in male apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2001; 21:1011-1016.
39. De Beer MC, Wroblewski JM, Noffsinger VP, et al. Deficiency of endogenous acute phase serum amyloid A does not affect atherosclerotic lesions in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2014; 34:255-261.
40. -/- mice. J Amer Heart Assoc 2015; 4.
41. Petri MH, Laguna-Fernandez A, Gonzalez-Diez M, et al. The role of the FPR2/ALX receptor in atherosclerosis development and plaque stability. Cardiovascular research 2015; 105:65-74.
42. -/-mice from angiotensin II-induced abdominal aortic aneurysm formation. Arterioscler Thromb Vasc Biol 2015; 35:1156-1165.
43. den Hartigh LJ, Wang S, Goodspeed L, et al. Deletion of serum amyloid A3 improves high fat high sucrose diet-induced adipose tissue inflammation and hyperlipidemia in female mice. PLOS ONE 2014; 9:e108564.
44. Krishack PA, Sontag TJ, Getz GS, Reardon CA. Serum amyloid A regulated (monopolies is) monopoiesis in hyperlipidemic LDLR-/- mice. FEBS Letters 2016; 590:2650-2660.